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ABSTRACT 
 
The aim of this overview is to review the evolution of the studies carried out, during more than 25 
years, on nanohydrogels obtained by self-assembling of pullulan (PUL) using several 
hydrophobization strategies. After the first publications, mainly devoted to the preparation and 
characterization of PUL nanogels, a remarkable number of studies demonstrated how wide can be 
the field of applications within the main topic of biopharmaceutics. Numerous hydrophilic and 
lipophilic drugs were entrapped in the nanogel networks, consequently PUL nanogels have been 
proposed as delivery systems for single drugs and for combination therapies which allowed 
improvements of pharmacological activities and patient compliance. Furthermore, the large amount 
of water content allowed loading also proteins which could maintain their native structure and 
properties. Stimuli-sensitive and stealth PUL nanogel formulations allowed improving the 
performances of antitumor drugs. These nanohydrogels have also been studied for imaging 
techniques and for vaccines to be administered by injection and by mucosal application. The studies 
on PUL nanogels are still in progress and the perspectives for future researches are also addressed. 
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INTRODUCTION 
 
Natural polysaccharides and their derivatives are indeed among the most employed and versatile 
polymeric materials that are actually used, or have been proposed, for hydrogel formulations [1]. 
In this sense it must be pointed out that polysaccharide hydrogels, whether chemically or physically 
based, show a wide variety of biomedical applications, ranging from their performances as drug 
carriers to their ability in living cell encapsulation; from bone and cartilage repair to the preparation 
of friendly scaffolds for tissue engineering. Furthermore, remaining within quite close areas of 
interest, polysaccharides are often present also in cosmetic and personal care products [2], are used 
as food additives [3] as well as in agriculture as fertilizer and for herbicide delivery [4], and have 
even been proposed in formulations for paper and painting cleaning [5, 6]. 
The peculiar and diversified properties of polysaccharides can be related to the different primary 
structures and molecular weights that these macromolecules may have, as well as to the various 
type and number of reactive groups that can be present on each single repeating unit. These 
properties allow numerous chemical modifications that can be appropriately tailored according to 
the specific use that is assigned to these macromolecules.  
It is well known that several natural polysaccharides are capable of forming gels in appropriate 
conditions. Typical examples are alginate, pectins and gellan, which are able to gel by means of the 
interactions between the carboxylic acid moieties and divalent ions (i.e., physical gelation by ion 
complexation); Locust Bean Gum and Xanthan whose synergistic interaction leads to gel formation 
[7, 8] and the stable hydrogels that can be formed by borax interaction with the hydroxyl groups of 
some polysaccharides [9].  
Furthermore, a large variety of bifunctional or multifunctional reagents have been used as 
crosslinking agents to chemically crosslink hydroxyl and/or other functional groups present on the 
native polysaccharide chains [10, 11]. 
On the other side it must be pointed out that numerous native polysaccharides are not capable to 
form hydrogels; moreover, in many cases the performances of hydrogels obtained from natural 
polysaccharides need significant improvements for their practical applications. For this purpose 
appropriate chemical modifications can be carried out on the macromolecules. Furthermore, 
sometimes scientists must resort to multicomponent networks such as semi-Interpenetrating 
Polymeric Networks (semi-IPNs) and Interpenetrating Polymeric Networks (IPNs) [12]. 
These networks usually show physico-chemical properties that can remarkably differ from those of 
the polymeric constituents and their properties, according to specific needs, can be tailored by the 
choice of the nature and the concentration of the interpenetrating macromolecules [13]. 
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Together with the methods used for polysaccharide hydrogel formation, schematically reported 
above, a relevant number of studies has been focused also to the size of the hydrogel networks for 
specific applications. Beside the bulk hydrogels, already studied since a long time, during last 
decades an ever-increasing attention has been devoted towards nanosized hydrogels 
(nanohydrogels/nanogels). Nanogels can be generally obtained following different techniques such 
as: polymerization of monomers in homogeneous or nano heterogeneous environments; chemical 
crosslinking of preformed monomers, top-down methods using lithography, template-assisted 
nanofabrication and physical self-assembly of interactive macromolecules. 
Only few polysaccharides have been exploited for nanohydrogel formation (e.g. hyaluronic acid, 
chitosan, gellan, scleroglucan, mannans) using different strategies, but in this review the attention 
will be focused on a single polysaccharide, pullulan (PUL). A wide overview on PUL and its 
derivatives was recently published with information about the various and diversified reactions that 
can be carried on this polysaccharide for different applications [14]; however, in the present work, 
our interest is specifically oriented towards a well defined topic: the self-assembling strategy for 
PUL nanogel formation and the possible applications of these nanostructures in the field of 
biomedicine, whose interest and importance is attested by the relevant number of publications that 
appeared in recent years. Actually, macromolecular self-assembly leading to nanostructures is being 
investigated since many years [15] because such processes are rather common in nature and also 
because of the wide variety of practical applications that such systems may have [16], in particular 
in the field of pharmaceutics. 
Different types of hydrophilic and amphiphilic polymer chains have been used for the preparation 
of nanogels suitable for diagnosis and/or therapy; in the case of polysaccharides, the spontaneous 
association leading to a nano-hydrogel is often achieved by an appropriate hydrophobic 
derivatization of these macromolecules [17], according to the general scheme of the process 
reported in Fig. 1. 
According to Kabanov and Vinogradov [16] a nanogel can be defined as “an aqueous dispersion of 
hydrogel particles formed by physically or chemically cross-linked polymer networks of nanoscale 
size”. Actually, when the self-assembling approach is used, these nano-structures are sometimes 
defined also as micelles, due to a certain similarity with surfactant micelles bearing a hydrophobic 
core and a hydrophilic shell [18], and in some studies the value of a critical micelle concentration 
has been identified and reported, as in the case of one of the first papers on hydrophobized PUL, 
where the more general term of nano-particles was used.  
Throughout this paper the terms nanohydrogel/nanogel and nanoparticle will be used as synonyms 
while the word micelle will be reported only when the authors of the mentioned articles specifically 
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selected this word to indicate the presence of single or multiple microdomains within the 
nanostructure. 
 
THE LONG STORY OF PULLULAN 
 
After some papers on the synthesis of cholesterol-modified pullulan (CHP) employed for liposome 
coating [19, 20], and just one year after the wide overview on molecular self-assembly as a strategy 
for the preparation of nanostructures reported in 1991 in Science [15], J. Sunamoto et al. [21, 22] 
gave preliminary information on self-aggregation of palmitoyl and cholesterol derivatives of several 
native polysaccharides such as amylopectin, dextran, mannan and PUL. It was evidenced that the 
critical concentrations leading to the polymer aggregates were strictly dependent on the degree of 
substitution of the hydrophobic moiety. Cholesterol-bearing PUL showed a stronger binding for 
hydrophobic guest molecules and a higher colloidal stability compared with the corresponding 
palmitoyl-bearing one; for this reason most of the following studies were carried out on CHP. The 
authors described also the physical cross-linking of cholesterol hydrophobized PUL for the 
formation of nanoparticles (hydrogels) capable to form a complex with various globular and soluble 
proteins such as haemoglobin, peroxidase, myoglobin, and cytochrome c. 
While in some preliminary approaches CHP was prepared via the aminoethyl-carboxymethyl-
derivative of the polysaccharide followed by the condensation with cholesteryl chloroformate, an 
improved procedure, which involved the synthesis of cholesteryl N-(6-isocyanatohexyl) carbamate 
and the subsequent condensation with PUL, was proposed in order to increase the stability of the 
nanogels. In most cases, the self-aggregated nanoparticles have been obtained by sonication in 
water but they could be prepared also by water dilution of a CHP solution in DMSO. The 
characterization of the system was carried out by size exclusion chromatography and the critical 
aggregation concentration was determined by fluorometry. The size and density of the hydrogel 
nanoparticles were related to the degree of cholesterol substitution. Dynamic Light Scattering 
(DLS) measurements indicated that the self-assembled structures had an average diameter of 25 ± 5 
nm, while negative stained electron microscopic observations showed the spherical shape of the 
particles. In all cases the obtained nanogels were stable in various environments and their size did 
not change for quite a long time even when kept at room temperature. Furthermore, it has been 
pointed out that, by appropriate variations of hydrophobic substitution degree and polymer 
concentration, CHP self-assembling can be controlled from the molecular level (association of 
hydrophobic groups) to the nanoscale (association of hydrophobized polymers) and macroscopic 
level (association of nanoparticles), as reported in the scheme of Fig. 2 [23, 24]. 
 6
The last sentence of one of the first papers by Akyoshi et al. [23] stated that “Since it is possible to 
bring cell specificity to the hydrophobized polysaccharides…they are expected to behave as novel 
carrier for various lipophilic drugs, proteins and so forth”. Actually, the applications of the 
nanohydrogels obtained following such approach, in particular with PUL, had since then such a 
wide development that it probably went even beyond the expectations of the authors of that paper.  
A short time later the same research group reported on the complexation of CHP with α-
chymotripsin (Chy). The CHP hydrogel strongly complexed with the Chy dimer leading to stable 
nanoparticles which showed an enhancement of thermal stability in both the structure and the 
enzymatic activity of the protein, which maintained its activity when released by the complex after 
addition of Bovine Serum Albumin (BSA). Furthermore, the treatment with pullulanase indicated 
that the enzyme should be located deeply inside the nanohydrogel network [25].  
The mild conditions needed for the spontaneous and easy formation of the complex between the 
hydrogel nanoparticles and proteins prompted to deeply investigate on insulin loading within the 
nanohydrogel just by mixing the two components. The supramolecular assembly was very stable, 
thus the complexed insulin was significantly protected from enzymatic degradation and at the same 
time aggregation was suppressed. Furthermore, in vivo studies demonstrated that insulin 
physiological activity was preserved after i.v. injection [26, 27].  
Enzymes, such as lipase, were also spontaneously complexed by mixing with the CHP nanogel. The 
thermal stability of the enzyme was significantly increased and aggregation was prevented even 
when induced by lyophilization. Size exclusion chromatography suggested that lipase located 
within the interior of the nanogel, which holds the protein molecule in the segregated nano-matrix 
by hydrophobic interactions [28] (Fig. 3). 
It is well known that in living systems molecular chaperones are capable to selectively trap, by 
hydrophobic interactions, denaturated proteins or their intermediates, thus preventing irreversible 
aggregations owing to specific macromolecular host-guest interactions. Similarly, CHP, due to its 
capacity to entrap proteins, may exert a chaperone-like function, as in the case of the above reported 
lipase [29]. Such chaperone-like activity for protein refolding using CHP has been studied with 
several enzymes (e.g. carbonic anhydrase, horseradish peroxidase, citrate synthase). The tested 
nanogels effectively prevented the protein inactivation by heat, guanidinium chloride or urea-
induced denaturation. The enzyme activity was recovered upon dissociation of the gel network in 
which the proteins were trapped, by addition of cyclodextrins (CD), according to the scheme 
reported in Fig. 4. Actually, it has been observed that CHP nanogels unfold dramatically in the 
presence of β-cyclodextrin: the hydrophobic cavity of β-CD rapidly screens the cholesterol group 
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along the PUL molecules by hydrophobic interactions, and such property suggests also that this 
hydrogel is suitable for a controlled drug delivery in hydrophobic environments [30 - 33]. 
The same approach was used to inhibit the formation of amyloid β-protein fibrils, which are 
considered as a key step in the pathology of Alzheimer’s disease [34]. 
Due to the fundamental role of CD in the destabilization of the association domains, DLS and Small 
Angle Neutron Scattering (SANS) were used for a deeper insight on the interaction of CHP with 
CD [35] and, more recently, an optical interferometric technique was used to monitor the swelling 
behavior of CHP gels with different substitution rates when exposed to different types of CD. 
Obtained results indicated that methyl-β-CD induced the largest swelling changes, while α-CD 
showed the lowest effect [36]. 
A recent study, which further extends the horizons of CHP applications, reports on the therapeutic 
effects that, using calvarian tissues from mouse embryos, can be reached by the use of such nanogel 
when loaded with the growth factor receptor sFGFR2S252W for the treatment of the Apert 
syndrome, a congenital disorder characterized by malformations of the skull, face, hands and feet 
[37]. 
Although most published papers on PUL-based self-assembled nanoparticles report studies on CHP, 
also other approaches have been proposed for the same purposes. An example is the PUL 
hydrophobization by acetylation. PUL acetate spontaneously self-assembled in water forming 
nanospherical aggregates. The drug-loading study was carried out using clonazepam as a 
hydrophobic drug and the corresponding release showed a pseudo-zero-order kinetics [38]. 
A variation of the above reported research was the coupling of the acetate hydrophobized PUL with 
carboxymethylated-poly(ethylene-glycol). The introduction of PEG was intended to induce stealth 
properties to the obtained nanoparticles, which were loaded with clonazepam. In vitro delivery 
experiments indicated that the release mechanism was related to the diffusion of the guest molecule 
from the core of the nanostructure [39]. 
Another self-assembled polymeric system based on carboxymethyl-pullulans, varying in the 
substitution rate on grafted alkyl chains, was proposed for the dissolution of poorly water-soluble 
drugs. Characterization of the obtained aggregates revealed the presence of hydrophobic 
nanodomains, which allowed a significant increase of the apparent solubility of benzophenone, 
while the solubility of docetaxel was only slightly improved because of the surface properties of the 
drug. In vitro cytotoxicity studies indicated that the new formulation was equipotent to the 
docetaxel commercial product and, at the same time, that the nano-structure, tested in the absence of 
the drug, was less cytotoxic against macrophages than the Tween80/ethanol-water system 
commonly used to increase drug solubility [40]. PUL nanocarriers, intended for nasal and lung 
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transmucosal delivery, were proposed by M. Dionísio et al. following a quite different approach. 
For this purpose, sulphated and aminated PUL derivatives were synthesized and the obtained 
charged polymers were complexed with chitosan or carrageenan to produce nanocarries, which 
were loaded with BSA as a model protein [41]. 
 
Environmental sensitive PUL nanohydrogels 
 
In order to induce a thermosensitive response to CHP, the hydrophobized PUL was hydrophobically 
combined with modified Poly(N-isopropylacrylamide) (HM-PNIPAM). The mixing of CHP and 
PNIPAM-C18Py yielded, via association of their hydrophobic groups, monodispersed nanogels 
which above 32 °C (i.e., the lower critical solution temperature of PNIPAM-C18Py) increased their 
diameter (from 47 to 160 nm), as demonstrated by fluorescence and DLS (Fig. 5 A). This 
phenomenon was thermoreversible and no aggregation was observed [42, 43]. 
A reversible and reproducible temperature-induced variation of hydrodynamic radius was observed 
also with hybrid nanogels obtained from CHP and PNIPAM synthesized by graft free-radical 
copolymerization of N-isopropylacrylamide (NIPAM) onto methacryloyl-substituted CHP nanogels 
in the presence of 2,2′-azobis[2-(2-imidazolin-2-yl)propane] as initiator. Depending on the ratio 
between the two components, different assemblies were obtained. In particular, it is interesting to 
point out that nanogels with a sufficiently high NIPAM content showed a two-step response to 
temperature variations (i.e. 35-30 and 35-50) as reported in Fig. 5 B. Such multi-step process was 
related to the specific grape-like morphology (botryoidal) acquired by the nanogel [44].  
In a following study thermosensitive PNIPAM hydrogels were prepared by crosslinking with self-
assembled nanogels consisting of cholesteryl- and methacryloyl-substituted PUL. The nanogel-
crosslinked PNIPAM showed a rapid deswelling and reswelling behaviour with temperature 
variations between 20 and 40 °C, as indicated in Fig. 5 C. Such property, which can be controlled, 
is to be considered useful for releasing hydrophobic molecules and proteins [45]. 
Within the ever-increasing family of stimuli-responsive delivery systems, together with the above 
reported thermosensitivity, a self-assembled cholesteryl PUL nanogel sensitive to pH was also 
studied. In this case an acid-labile cholesterol (CHOL) derivative was bound to PUL by vinyl ether 
groups; the obtained product was then hydrolyzed in acidic medium, as reported in Fig. 6 [46]. 
When complexed with a model protein (BSA) in a neutral environment, the cargo was released at a 
rate which was controlled by the degradation of the CHOL-PUL grafting moiety.  
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Antitumor self-assembled PUL nanohydrogels 
 
A different approach was followed by Na et al. [47, 48]: self-organized thermo-responsive nanogels 
from pullulan-g-poly(L-lactide) were prepared by one-pot method. The nanoparticles, consisting of 
hydrophobic cores of poly(L-lactide) and hydrophilic outer-shells of PUL, were characterized and 
the critical association concentration was evaluated. According to the ratio between PUL and poly 
(L-lactide), products with different properties were obtained and one of them was selected as that 
with the best performances. Doxorubicin (DOX) was loaded in the nanogels, which showed good 
encapsulation efficiency. A significant difference in DOX release was observed between 37 and 
42 °C as well as the 50% inhibitory concentration values evaluated at the two temperatures. 
According to the obtained results the authors suggested that such nanogels, by means of a triggering 
temperature, can be used as long-term delivery systems for cancer therapy.  
DOX was also loaded in pH-sensitive nanoparticles obtained by conjugation of both urocanic acid 
(as pH-sensitive moiety) and cholesterol succinate (as hydrophobic moiety). A high drug loading 
was obtained and results of MTT assays, flow cytometry and confocal microscopy confirmed that 
such nanostructures were able to realize an intracellular delivery after internalization and a 
corresponding enhanced cytotoxicity of the drug against MCF-7 cells [49]. 
A different class of PUL-based self-assembled pH responsive nanohydrogel was proposed for 
adriamycin delivery. In this case the nanoparticles were obtained by conjugating sulfadimethoxine 
to succinylated PUL acetate and the release of the loaded anticancer drug was tested at different pH 
conditions. This approach appeared to be suitable for an improved passive accumulation and 
enhanced drug release at tumor pH values [50]. Furthermore, such accumulation capability exerted 
by PUL acetate allowed preparing nanoparticles as effective intratumoral radioisotope 
(99mTechnetium) carriers for cancer treatment via radiotherapy [51]. 
Acetate-hydrophobized PUL was used also for paclitaxel incorporation and the obtained self-
assembled particles containing the drug were tested both in vitro and in vivo. While in vitro a lower 
antitumor activity with respect to the free drug was observed because of the sustained release 
properties of the system, in vivo tests using human colon carcinoma cells, showed a higher 
reduction in tumor volume [52]. 
Together with CHP, also α-tocopherol PUL polymers (PUTC) showed self-assembling properties. 
The nanomicelles (as named by the authors), obtained from PUTC by sonication and dialysis, were 
capable to load 10-Hydroxycamphothecin (HCTP) at different percentages according to the 
substitution degree (Fig. 7). In vitro experiments indicated that blank PUTCs were biocompatible 
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with MCF-7 cells and that the HCTP-loaded nanostructures were more toxic than the free drug due 
to an increased cellular uptake [53]. 
More recently, by coupling CHOL to PUL via disulfide bond, reducible nanoparticles (rCHP) were 
obtained. When loaded with DOX, the nanoparticles released the drug in a reduction-sensitive 
manner and the growth of HepG2 cells was inhibited. Furthermore, a remarkable antitumor effect 
was detected in nude mice bearing hepatocellular carcinoma tumors, which was related to an 
enhanced internalization by receptor-mediated endocytosis and to an accelerated drug release in 
tumor cells [54].  
A completely different approach was followed by other authors who hydrophobized PUL 
derivatives by conjugating the drug itself on the polysaccharide macromolecule. A combination 
therapy against hepatocellular carcinoma was proposed by Wang et al. [55]: in this case self-
assembling was induced by methotrexate which was conjugated with the pH-sensitive N-urocanyl 
derivative of PUL. The nanoparticles, obtained by the dialysis method, exhibited a high affinity for 
specific hepatic cells and were also capable to upload the anti-angiogenic combretastatin A4. By 
intravenous injection in mice, the new formulation showed a prolonged circulation time in the blood, 
an increased distribution in the liver and in the tumor cells with respect to the original drug. 
Another pH sensitive system was prepared from urocanyl PUL and it was demonstrated that the 
obtained nanoparticles, when tested as adriamycin carriers, were capable to overcome drug 
resistance of cancer cells by entering into the nucleus of MCF-7/ADR cells [56]. 
The above-mentioned methotrexate was studied also for a hepatoma-targeted co-delivery of gene 
and chemotherapy agent. In this case the methotrexate-hydrophobized PUL did not actually form 
the main self-assembled structure but only the outer coating of an inner nanoparticle core obtained 
from the condensation of plasmid DNA expressing green fluorescent protein with poly(β-
amino)ester. This complex structure exhibited a significant synergic effect on hepatoma cells, 
evidenced by a high gene transfection capability and an enhanced cytotoxicity, together with strong 
hepatoma-targeting properties, both at cellular and animal level [57]. 
Also the DOX molecule was proposed for the polysaccharide hydrophobization. The chemical link 
of the drug to PUL was obtained through the formation of a pH-sensitive hydrazone bond by 
reacting the amidated PUL with DOX·HCl. The DOX content in the conjugates increased with the 
increase of DOX in the reaction. Spontaneous self-aggregation in aqueous media of the PUL-DOX 
conjugates gave nanoparticles of different sizes according to the initial amidated PUL/DOX·HCl 
ratio. The conjugated DOX was released in a pH-responsive manner. PUL, which was present at the 
shell of the nanoparticles, provided an active targeting to hepatic cells through a specific interaction 
with asialoglycoprotein receptors on the membrane of the tested cells. Due to such properties, these 
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new self-aggregated structures have been considered as suitable tools for liver-targeted antitumor 
chemotherapy [58]. 
In order to couple anti-cancer and targeting properties within the same PUL nanohydrogel network, 
folate-PUL conjugates (FA/PUL), with different degree of substitution, were prepared. The 
obtained FA/PUL polymers were capable to form spontaneously self-organized networks which 
showed different DOX-loading and releasing properties related to the degree of FA substitution. 
Cellular uptake and internalization of the FA/PUL nanohydrogels studies demonstrated that the 
novel nanogel is suitable for active targeting chemotherapy [59]. FA was also proposed for the 
decoration of maleilated PUL nanoparticles which were conjugated with DOX (FA-MP-DOX). The 
obtained system was more effective against ovarian carcinoma cells that the free drug [60]. 
Furthermore, when pyrroditiocarbamate was also loaded in the FA-MP-DOX nanostructures, a 
significant increase of activity against DOX-resistant ovarian carcinoma cells was observed, thus 
indicating that such formulation may have important clinical implications to overcome multidrug 
resistance [61]. 
The targeting properties of FA/PUL were also exploited for a photodynamic therapy based on the 
conjugation of a photosensitizer (pheophorbide-a) with FA/PUL. When such nanohydrogels, with 
self-quenchable photoactivity, were co-incubated with HeLa cells, a noticeable increase in 
photoactivity was detected; furthermore, after subcutaneous injection in mice a significant 
phototoxicity, which became negligible in darkness, was observed [62].  
Since several studies revealed that biotin receptors are over-expressed on several tumors 
characterized by rapid and aggressive growth, biotin-modified CHP nanogels have been proposed 
as anticancer drug carriers. When loaded with mitoxantrone the obtained self-aggregated structures 
showed, after an initial burst effect, a sustained release of the drug [63]. 
Another approach for drug targeting, in this case for protein delivery to myeloma cells and primary 
T lymphocytes, both with low heparin sulphate expression, was proposed using cationic CPH 
nanogels (cCHP) which were previously described for intracellular BSA delivery [64]. Obtained 
results indicated that the anti-apoptotic protein Bcl-xL delivered by cCHP efficiently blocked 
apoptosis of the tested cells, suggesting that this cationic nanogel can represent a useful tool to 
deliver proteins for functional regulation of cells that poorly express heparin sulphate [65]. 
It interesting to point out that, taking advantage from the possibility of obtaining an intracellular 
delivery, as above reported, it has been possible to use CHP modified with amino groups as novel 
carriers of quantum dots. The effective internalization of such nanogel-quantum dot hybrid 
nanoparticles into several human cells demonstrated that cellular uptake was significantly higher 
with respect to other conventional carriers and that the new system can be useful as a fluorescent 
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probe for bioimaging [66, 67]. Taking into account that human mesenchymal stem cells (hMSCs) 
have been found to improve cancer therapy and diagnosis due to their tumor-homing properties [68], 
early tumors (~3 mm3) were detected, using magnetic resonance and optical imaging both in vitro 
and in vivo, by means of PUL-deoxycholic acid-diethylene triamine pentaacetic gadolinium-chelate 
nanoparticles photochemically internalized in hMSCs [69]. 
 
PUL nanohydrogels for protein/gene/vaccine delivery 
 
Together with other polymeric nanohydrogels, also PUL based self-assembled networks have been 
proposed as vaccine delivery systems [70]. 
Taking into account that the overexpression of human epidermal growth factor receptor 2 (HER2) is 
often detected in adenocarcinomas such as breast, ovarian, lung, and gastric cancer, humoral 
immune responses were studied in patients vaccinated with HER2 oncoprotein complexed with 
CHP (CHP-HER2) and with CHP-HER2 plus granulocyte-macrophage colony-stimulating factor 
(GM-CSF). The formulations, which were considered safe, successfully induced specific CD8+ and 
CD4+ T cells responses against HER2+ tumors and GM-CSF seemed to accelerate such responses 
[71 - 73]. 
CHP was used also in combination with New York-esophagus-1 (NY-ESO-1). Obtained results, 
carried out in vitro, showed that CHP/ESO-loaded dendritic cells efficiently stimulated CD8 and 
CD4 cells, thus indicating that such system can represent a promising polyvalent vaccine for 
immunotherapy targeting NY-ESO-1 [74]. 
Following such encouraging results a phase I clinical trial was designed to evaluate the safety, 
immune response and tumor response in esophageal cancer patients, malignant melanoma and 
prostate cancer patients. The use of whole protein, containing multiple CD4 and CD8 epitopes, was 
considered beneficial for cancer vaccines to prevent tumors from evading to immune response, and 
in most of prostate cancer patients, PSA values stabilized during vaccination [75].  
In a following study, vaccines of NY-ESO-1 and HER2, both complexed with CHP, were tested. 
The results obtained with such vaccine combination indicated, in esophageal cancer patients, that 
the responses to NY-ESO-1 were comparable to the single vaccine, while for HER2 only fewer 
antibody responses were observed [76]. More recently, clinical trials, carried out on patients with 
antigen-expressing esophageal cancer, confirmed the safety and immunogenicity of the NY-ESO-1-
CHP complex and demonstrated that, after subcutaneous vaccination with the higher tested dose 
(200 μg), immune responses were efficiently induced with better survival benefits [77]. 
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Taking into account that a variety of cytokines have proved to be effective in inducing immune 
responses to eliminate tumor cells, CHP was proposed also as a drug delivery system for tumor 
immunotherapy by IL-12 sustained release. Repetitive subcutaneous administrations of IL-12 
loaded CHP induced, in the tested mice, a drastic delay in the growth of fibrosarcoma which was 
not observed with IL-12 alone [78]. 
Since mucosal vaccination is considered a suitable and practical route of immunization capable to 
induce effective immunity to infectious diseases, CHP nanogels were also tested as antigen delivery 
systems for nasal vaccines. 
According to such purpose a complex formed by a cationic cholesteryl group-bearing PUL above 
described  (cCHP) [65] and a non-toxic subunit fragment of Clostridium botulinum type A 
neurotoxin (BoHc/A) was intranasally administered to mice. The cCHP-BoHc/A system was 
effectively taken up by mucosal dendritic cells and vigorous BoHc/A neutralizing serum IgG and 
secretory IgA antibody responses were induced without co-administration of mucosal adjuvants 
[79]. 
Following a similar approach, a pneumococcal vaccine was developed which consisted in the 
complex formed by cCHP with pneumococcal surface protein (PspA). The efficacy of such 
cCHP/PspA nasal vaccine was tested in murine pneumococcal airway infection models. Intranasal 
vaccination with this new nanogel-based complex provided protective immunity against lethal 
challenge with Streptococcus pneumoniae, prevented colonization and invasion by bacteria in the 
respiratory tract, induced systemic and nasal mucosal Th17 responses. In both reported studies, no 
signs of BoHc/A or PspA delivery to olfactory bulbs and central nervous system were detected [80].  
A review on nanogel-based systems suitable for antigen delivery by mucosal application, published 
in 2013, underlines the wide possibilities represented by this type of vaccines for the prevention of 
infectious diseases [81]. 
A more recent study demonstrated that CHP is also suitable for selective vaccine delivery to 
medullary macrophages, selective vaccination behaving as a stealth nanoparticulate delivery system. 
Obtained results, schematically reported in Fig. 8, together with the parallel observation that 
medullary macrophages have a potential to effectively induce specific CD8+ T cell response to 
vaccine, represent, according to the authors, an important step for the design of macrophage-
oriented cancer vaccines with high potency [82].  
The possibility to stabilize proteins by their loading in nanohydrogel structures was exploited also 
for the improvement of etanercept effect in rheumatoid arthritis treatment. The approach was based 
on a temperature-induced modulation of non covalent interactions between a negatively charged 
amphiphilic PUL derivative (succinylated PUL-g-oligo(L-lactide)) and the positively charged 
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etanercept. The obtained nano-system improved the long-term stability of the protein and, when 
tested in vivo on rats, allowed a prolonged release and an outstanding therapeutic activity in the 
arthritis animal model after subcutaneous administration [83]. 
The success of SiRNA for gene therapy and the need of appropriate carriers capable to provide 
specific cells with therapeutic concentrations of such macromolecules induced to investigate the 
possible use of PUL derivatives for a liver-targeted SiRNA delivery. For this purpose 
polyethylenimine-PUL (PPE) was tested and the obtained nanoparticles, when loaded with 
fluorescein-labeled SiRNA, led to an increased fluorescence level in the liver of mice with respect 
to other organs, after systemic injection. Such result, together with the low toxicity detected for the 
carrier, suggests that the system can be considered as a useful tool for an efficient delivery of 
SiRNA to the liver [84]. Furthermore, it was pointed out that PPE shows excellent blood 
compatibility and good transfection efficiency of pGFP and pGL3 on HepG2 cells also in the 
presence of serum [85]. 
 
Scaffolds from PUL nanohydrogels 
The possibility to entrap, within PUL nanogels, proteins which maintained their native structure and 
properties, allowed proposing such structures as tools suitable for tissue regeneration. For this 
purpose acryloyl-group-bearing CHPs (CHPA) were synthesized by DCC-mediated condensation; 
then, after bone morphogenetic protein (BMP2) loading into the obtained nanogel, an aggregation 
process was carried out which led to the formation of a “nanogel in hydrogel” structure. 
Implantation of such gel induced osteoblastic activation, new bone formation in vivo and allowed to 
heal calvarian defects which did not heal spontaneously [86]. Similarly, complete healing of mice 
calvarian defects were obtained by co-administration of two bone growth factors (FGF18 and 
BMP2) embedded in a hydrogel matrix prepared by aggregation of CHPA [87]. Following an 
analogous approach, a multiarmed poly(ethylene glycol) (PEGSH) was used as a crosslinker for the 
building blocks of CHPA leading to a physically crosslinked network formed by self-assembly of 
amphiphilic polysaccharide and a chemically crosslinked network among the nanogels (NanoCliP) 
[88]. The porous NanoCliP was able to trap proteins (e.g. insulin), liposomes and cells; furthermore, 
when subcutaneously transplanted into mice, it stimulated cell infiltration, tissue ingrowth and 
neovascularization [89]. Due to all these properties, the NanoCliP gel, according the authors, 
“represents a new universal platform as a scaffold for tissue engineering” 
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CONCLUSIONS 
 
Although this overview is intentionally limited to a single polysaccharide and to its 
hydrophobization which leads to nanohydrogel formation by self-assembling, it is evident, from the 
above reported results obtained during the last twenty-five years, how wide can be the use of such 
nanoparticles within the field of pharmaceutical applications. Beside the different self-assembling 
strategies that can be followed, PUL nanogels have been shown as suitable carriers for small 
biologically active agents as well as for biomacromolecules. Due to the extremely high water 
content of the hydrogel environment and the mild loading conditions, entrapped proteins can 
maintain their native overall structure and properties and, in case, exert also chaperone-like 
functions. At the same time the hydrophobic microdomains present in these structures allow to 
increase the solubility and efficacy of poorly soluble substances. Consequently, PUL nanogels have 
been proposed as targeting and delivery systems for single drugs and for combination therapies 
which can lead to improvements of pharmacological activities and patient compliance. Stimuli-
sensitive PUL nanogel formulations together with the possibility to induce, when needed, stealth 
properties to the nanoparticles, allowed to enhance the performances of antitumor drugs; 
furthermore, these nanohydrogels have also been studied for imaging, for vaccines to be 
administered by injection and by mucosal application and as scaffolds for tissue engineering.  
Despite the relevant amount of publications on PUL nanogels it can be stated that we are not at the 
end of the story: further improvements can still be reached with this multitasking nanostructure 
which should sometimes be combined with parallel studies. As an example, a more accurate 
identification of immunological biomarkers, together with the improvement of nanogels complexed 
with antigens, should allow a better evaluation of the clinical response to cancer immunotherapy. 
Also the combination of imaging with therapeutic applications (theranostics) still appears to be only 
at its early stage and needs to be further developed and several “last generation” drugs and vaccines, 
as those obtained through DNA recombinant techniques, could probably be fruitfully administered 
using this type of nanogels. Moreover, it can be stated that the wide experience acquired with PUL 
systems should be more systematically applied also to other polysaccharides, thus leading to even 
better performances of these nanostructures.  
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